FDA
approval
· 2023-10-18
FDA Approved: SITAGLIPTIN — Original Application (Zydus Lifesciences Limited)
Summary
FDA approved a sitagliptin product under an Original Application from Zydus Lifesciences Limited for type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SITAGLIPTIN (SITAGLIPTIN)